Related Experiment Video

Updated: Mar 13, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

832

Mdm2-RNA Interactions as a Target for Cancer Therapy: It's Not All About p53

Stephen Bohlman1, James J Manfredi1

  • 1Department of Oncological Sciences and The Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Cancer Cell
|October 12, 2016
PubMed

Insights

Researchers identified small molecules that block Mdm2 protein binding to XIAP mRNA. This dual-action approach lowers levels of both proteins, offering a new cancer therapy strategy regardless of p53 gene status.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • The Mdm2 protein regulates the expression of XIAP, an anti-apoptotic protein.
  • XIAP plays a role in cancer cell survival and resistance to apoptosis.
  • Targeting Mdm2-XIAP mRNA interaction is a potential therapeutic strategy.

Purpose of the Study:

  • To characterize small molecules that inhibit the Mdm2-XIAP mRNA interaction.
  • To evaluate the effect of these molecules on Mdm2 and XIAP protein expression.
  • To assess the therapeutic potential of this approach in cancer cells.

Main Methods:

  • High-throughput screening for small molecules targeting Mdm2-XIAP mRNA interaction.
  • Western blot analysis to determine protein expression levels.
  • Cell-based assays to evaluate apoptosis and tumor cell viability.

Main Results:

  • Identification of novel small molecules inhibiting Mdm2-XIAP mRNA interaction.
  • Demonstrated simultaneous decrease in Mdm2 and XIAP protein expression.
  • Observed anti-cancer effects independent of p53 status.

Conclusions:

  • Small molecules targeting Mdm2-XIAP mRNA interaction represent a novel therapeutic strategy.
  • This approach effectively reduces expression of key proteins involved in cancer cell survival.
  • The p53-independent mechanism offers broad applicability in various tumor types.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

479

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K